To Study the Association between Metabolic Syndrome and Breast Cancer among Premenopausal Females
Insulin resistance, particularly insulin resistance as reflected by elevated HOMA-IR, is strongly associated with breast cancer in premenopausal women and underscores the importance of early identification and management of metabolic abnormalities as potential strategies for breast cancer risk reduction and prognostication in premenopausal females.